NRx Pharmaceuticals: $5M Boost for NRX-101 Drug
NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...
- Latest
- Trending
NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...
MetLife strengthens enterprise data solutions with the appointment of Michelleta Razon as Head of Data Enablement, enhancing decision-making and innovation. ...
YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Assure Holdings announces merger agreement with Danam Health, creating a Nasdaq-listed entity in pharmaceutical and healthcare sectors. The merger is ...
Dick's Sporting Goods receives positive mention and promising outlook from a Midwest Boutique firm, reflecting strong performance and effective inventory ...
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...
Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
WiSA Technologies, Inc. has priced its public offering at approximately $10 million as part of its expansion plans in the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.